https://www.indianpharmapost.com/granules-indias-gagillapur-facility-completes-usfda-inspection-with-six-observations-161482024-09-09T00:00:00+05:30always0.9https://www.indianpharmapost.com/suspected-mpox-case-under-investigation-161492024-09-09T00:00:00+05:30always0.9https://www.indianpharmapost.com/briefs-ami-organics-and-dr-reddys-laboratories-161502024-09-09T00:00:00+05:30always0.9https://www.indianpharmapost.com/ifinatamab-deruxtecan-continues-to-demonstrate-promising-response-rates-for-lung-cancer-in-phase-2-trial-161512024-09-09T00:00:00+05:30always0.9https://www.indianpharmapost.com/lilly-and-eva-pharma-collaborate-to-expand-access-to-baricitinib-across-49-low-to-middle-income-countries-in-africa-161522024-09-09T00:00:00+05:30always0.9